Molecular basis of NDM-1, a new antibiotic resistance determinant

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Liang, Zhongjie ^a   Li, Lianchun ^a,b   Wang, Yuanyuan ^a   Chen, Limin ^a   Kong, Xiangqian ^a   Hong, Yao ^b   Lan, Lefu ^a   Zheng, Mingyue ^a   Guang Yang, Cai ^a   Liu, Hong ^a   Shen, Xu ^a   Luo, Cheng ^a,c   Li, Keqin Kathy ^b   Chen, Kaixian ^a   Jiang, Hualiang ^a,d  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^b SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^c SOOCHOW UNIVERSITY   (China)

^d EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZTREONAM; CARBAPENEM; CEFOTAXIME; CEFPIROME; CEFTAZIDIME; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE; NDM 1 PROTEIN; TIGECYCLINE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BETA LACTAMASE; BETA LACTAMASE FEZ 1; BETA LACTAMASE NDM 1; BETA-LACTAMASE FEZ-1; BETA-LACTAMASE NDM-1; CARBAPENEM DERIVATIVE; THIENAMYCIN DERIVATIVE; VIM 2 BETA LACTAMASE; VIM-2 BETA-LACTAMASE; ZINC;

ACCURACY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; CATALYSIS; CONTROLLED STUDY; DOWN REGULATION; DRUG DEGRADATION; ENZYME ANALYSIS; HYDROLYSIS; MUTAGENESIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN STRUCTURE; THREE DIMENSIONAL IMAGING; BIOCATALYSIS; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECT; ENZYME ASSAY; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; POINT MUTATION; PROTEIN BINDING; SEQUENCE ALIGNMENT; STRUCTURAL HOMOLOGY;

ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; BIOCATALYSIS; CARBAPENEMS; CONSERVED SEQUENCE; DRUG RESISTANCE, MICROBIAL; ENZYME ASSAYS; HYDROLYSIS; MODELS, MOLECULAR; POINT MUTATION; PROTEIN BINDING; SEQUENCE ALIGNMENT; STRUCTURAL HOMOLOGY, PROTEIN; THIENAMYCINS; ZINC;

EID: 80051955677     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023606     Document Type: Article

References (20)

1. Yong D, Toleman MA, Giske CG, Cho HS, Sundman K, et al. (2009) Characterization of a New Metallo-Lactamase Gene, blaNDM-1, and a Novel Erythromycin Esterase Gene Carried on a Unique Genetic Structure in Klebsiella pneumoniae Sequence Type 14 from India. Antimicrobial Agents and Chemotherapy 53: 5046-5054.
2. Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F, et al. (2010) Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 10: 597-602.
3. Rolain JM, Parola P, Cornaglia G, (2010) New Delhi metallo-beta-lactamase (NDM-1): towards a new pandemia? Clin Microbiol Infect 16: 1699-1701.
4. Wang Z, Fast W, Valentine AM, Benkovic SJ, (1999) Metallo-beta-lactamase: structure and mechanism. Curr Opin Chem Biol 3: 614-622.
5. Bounaga S, Laws AP, Galleni M, Page MI, (1998) The mechanism of catalysis and the inhibition of the Bacillus cereus zinc-dependent beta-lactamase. Biochem J 331: 703-711.
6. Wang Z, Fast W, Benkovic SJ, (1999) On the mechanism of the metallo-beta-lactamase from Bacteroides fragilis. Biochemistry 38: 10013-10023.
7. Park H, Brothers EN, Merz KM, (2005) Hybrid QM/MM and DFT investigations of the catalytic mechanism and inhibition of the dinuclear zinc metallo-beta-lactamase CcrA from Bacteroides fragilis. J Am Chem Soc 127: 4232-4241.
8. Lassaux P, Traore DA, Loisel E, Favier A, Docquier JD, et al. (2011) Biochemical and Structural Characterization of the Subclass B1 Metallo-{beta}-Lactamase VIM-4. Antimicrob Agents Chemother 55: 1248-1255.
9. Zhang H, Hao Q, (2011) Crystal structure of NDM-1 reveals a common {beta}-lactam hydrolysis mechanism. FASEB J.
10. Guo Y, Wang J, Niu G, Shui W, Sun Y, et al. (2011) A structural view of the antibiotic degradation enzyme NDM-1 from a superbug. Protein Cell 2: 384-394.
11. Moali C, Anne C, Lamotte-Brasseur J, Groslambert S, Devreese B, et al. (2003) Analysis of the importance of the metallo-beta-lactamase active site loop in substrate binding and catalysis. Chem Biol 10: 319-329.
12. Yamaguchi Y, Jin W, Matsunaga K, Ikemizu S, Yamagata Y, et al. (2007) Crystallographic investigation of the inhibition mode of a VIM-2 metallo-beta-lactamase from Pseudomonas aeruginosa by a mercaptocarboxylate inhibitor. J Med Chem 50: 6647-6653.
13. Lassaux P, Hamel M, Gulea M, Delbruck H, Mercuri PS, et al. (2010) Mercaptophosphonate compounds as broad-spectrum inhibitors of the metallo-beta-lactamases. J Med Chem 53: 4862-4876.
14. Garcia-Saez I, Mercuri PS, Papamicael C, Kahn R, Frere JM, et al. (2003) Three-dimensional structure of FEZ-1, a monomeric subclass B3 metallo-beta-lactamase from Fluoribacter gormanii, in native form and in complex with D-captopril. J Mol Biol 325: 651-660.
15. Bebrone C, (2007) Metallo-beta-lactamases (classification, activity, genetic organization, structure, zinc coordination) and their superfamily. Biochem Pharmacol 74: 1686-1701.
16. Yu K, Luo C, Qin G, Xu Z, Li N, et al. (2009) Why are oseltamivir and zanamivir effective against the newly emerged influenza A virus (A/H1N1)? Cell Research 19: 1221-1224.
17. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ, (1990) Basic local alignment search tool. J Mol Biol 215: 403-410.
18. Laskowski RA, MacArthur MW, Moss DS, Thornton JM, (1993) PROCHECK: a program to check the stereochemical quality of protein structures}. Journal of Applied Crystallography 26: 283-291.
19. Bowie JU, Luthy R, Eisenberg D, (1991) A method to identify protein sequences that fold into a known three-dimensional structure. Science 253: 164-170.
20. Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, et al. (2004) Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem 47: 1739-1749.